Introduction: The evaluation and treatment of pain in hospitalized is still an important health problem. Objective: To know the prevalence, characteristics and approaches to pain management in children and adolescents hospitalized in the Pediatric Hospital of the Pereira Rossell Center (HP-CH-PR), a pediatric reference center in Uruguay. Patients and Method: Cross-sectional study, through survey and review of clinical records on 09/13/16. All hospitalized children under the age of 19 were included. Variables: age, gender, reason for admission, presence of cognitive disorder, the prevalence of pain at some time during hospitalization, in the last 24 hours and during the interview, cause of maximum pain, intensity, pharmacological and non-pharmacological treatment. Results: 97.4% (152/156) hospitalized children were included. Pain prevalence at some point during hospitalization: 51.3% (78/152, 95% CI: 43.2-59.3); in the previous 24 hours: 39.5% (60/152, 95% CI: 31.7-47.2); during the interview: 15.8% (24/152, 95% CI: 10-21.5). Intensity: mild 13/24, moderate-severe 11/24. Maximum pain referred during hospitalization: needle punctures 48.5% (38/78). They had some analgesic prescription 47.3% of them had some analgesic prescription. Inadequate interdose interval: 45.8%; adequate dose 98.9%; intravenous administration: 43.7%; contraindication to oral route: 40.5%. Conclusions: Regarding children and adolescents hospitalized, 39.5% reported pain 24 hours before being the interviewed and 15.8% reported pain during the interview. The maximum pain reported during hospitalization was due to needle punctures. Children in pain with inappropriate analgesic prescriptions are still detected.
Introducción: en Uruguay se ofrece gratuitamente una vacuna tetravalente contra el virus del papiloma humano (VPH) a todas las adolescentes de 12 años o mayores. Las coberturas logradas no han sido las esperadas. Objetivo: describir el estado vacunal contra el VPH, motivos de no vacunación y reporte de efectos adversos en las adolescentes hospitalizadas en un centro de referencia en Uruguay. Material y método: estudio descriptivo mediante encuesta anónima a adolescentes de 12 años o mayores hospitalizadas en cuidados moderados del Hospital Pediátrico del Centro Hospitalario Pereira Rossell durante el segundo semestre de 2016. Se excluyeron las adolescentes que se negaron a participar, las portadoras de retardo mental o pasibles de cuidados paliativos. Se analizó: edad, estado vacunal contra VPH, motivos de no vacunación y de rechazo a la vacuna, efectos adversos. Fue aprobado por el Comité de Ética de la institución. Resultados: se encuestaron 112 adolescentes. Edad media: 13,5 años (12-14,6). Reportaron recibir al menos una dosis de la vacuna contra VPH: 45/112 (40,1%). Motivo de no vacunación más frecuente reportado: desconocimiento de la existencia de la vacuna: 48/67 (71,6%), seguido de rechazo o negativa de la adolescente o adulto responsable: 13/67 (19,4%). El principal motivo de rechazo a recibir la vacuna fue la falta de información: 7/13. No se registraron efectos adversos graves. Conclusiones: se observó una cobertura vacunal similar a datos nacionales. El conocimiento y la información de las adolescentes y sus cuidadores sobre esta vacuna fueron los principales motivos de no vacunación detectados.
Derivados cannábicos para uso medicinal en niños y adolescentes: aportes para un uso responsable y seguro Contributions for the safe and reliable use of medicinal cannabis derivatives by children and adolescents Contribuições para o uso responsável e seguro dos derivados da cannabis medicinal para crianças e adolescentes
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.